Janumet XR tablet 100/1000 mg

COMBINATION_PRODUCT2 trials

Sponsors

GL Pharm Tech Corporation

Conditions

Healthy

Phase 1

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers

CompletedNCT03851341

GL Pharm Tech CorporationHealthy

Start: 2019-01-02End: 2019-01-18Updated: 2019-04-24

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

CompletedNCT03927170

GL Pharm Tech CorporationHealthy

Start: 2019-05-02End: 2019-10-23Updated: 2020-07-23